四神丸通过抑制Wnt/β-catenin通路减轻实验性慢性结肠炎的药理机制
该研究探讨四神丸(SSW)治疗实验性慢性结肠炎的药理机制。采用TNBS诱导大鼠慢性结肠炎模型,SSW治疗10天,通过结肠重量、长度、病理评分、ELISA、TUNEL和Western blot评估疗效与Wnt/β-catenin通路变化。结果表明SSW改善结肠损伤,其机制与抑制Wnt/β-catenin信号通路相关。
要点
- 四神丸可改善TNBS诱导的大鼠慢性结肠炎宏观与微观损伤。
- 四神丸升高结肠黏膜ATP水平,抑制β-catenin及下游蛋白表达。
- 四神丸通过抑制Wnt/β-catenin通路发挥抗慢性结肠炎作用。
核心结论
- 四神丸有效减轻TNBS诱导的实验性慢性结肠炎,其机制通过抑制Wnt/β-catenin信号通路实现。
研究设计与样本
- 采用TNBS诱导大鼠实验性慢性结肠炎模型,四神丸治疗10天。
- 通过结肠重量、结肠长度和病理评分分析疗效,ELISA检测细胞因子,TUNEL检测凋亡,Western blot分析Wnt/β-catenin通路蛋白。
主要发现
- 四神丸改善结肠宏观和微观损伤。
- 四神丸升高结肠黏膜ATP水平。
- 四神丸抑制β-catenin、Nemo样激酶相关环指蛋白泛素化、T细胞因子及Wnt/β-catenin下游蛋白(包括c-Myc、环氧化酶-2、细胞周期蛋白D1、survivin、信号转导与转录激活因子3和拉链相互作用蛋白激酶)的表达。
- 四神丸改善淋巴增强因子泛素化并提高β-TrCP活性,随后引起结肠上皮细胞过度凋亡。
临床怎么用
- 四神丸可作为治疗慢性结肠炎的候选中药制剂,其作用与抑制Wnt/β-catenin通路相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Sishen Wan (SSW) is a commercial and frequently used Chinese patent medicine listed in the Chinese Pharmacopeia, which is usually used to treat chronic colitis. AIM OF THE STUDY: We explored the pharmacological mechanism of Sishen Wan attenuated experimental chronic colitis by inhibiting Wnt/β-catenin pathway. MATERIALS AND METHODS: Experimental chronic colitis was induced by trinitrobenzene sulfonic acid (TNBS). The therapeutic effect of SSW were analyzed by index of colonic weight, colonic length, pathological score. Cytokines expression were analyzed by ELISA, while the apoptosis level was checked by TUNEL staining. These proteins of Wnt/β-catenin signaling pathway was analyzed by Western blot assay. RESULTS: Rats with TNBS-induced chronic colitis were treated by SSW for 10 days. The efficacy of SSW was demonstrated by improved macroscopic and microscopic colonic damage. SSW increased the level of ATP in colonic mucosa, while SSW inhibited β-catenin, ubiquitination of Nemo-like-kinase-associated ring finger protein and T-cell factor, and expression of Wnt/β-catenin downstream proteins (including c-Myc, cyclo-oxygenase-2, cyclin D1, survivin, signal transducer and activator of transcription 3 and zipper-interacting protein kinase), and improved lymphoid enhancer factor ubiquitination and β-TrCP activity, followed by excessive apoptosis of colonic epithelial cells. CONCLUSIONS: SSW effectively attenuated experimental chronic colitis induced by TNBS, which was realized by inhibition of the Wnt/β-catenin signaling pathway.
引用
- Zhao HM, Liu Y, Huang XY, et al. Pharmacological mechanism of Sishen Wan® attenuated experimental chronic colitis by inhibiting wnt/β-catenin pathway. J Ethnopharmacol. 2019. PMID: 31078692. doi:10.1016/j.jep.2019.111936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。